इअरकार्ट IPO वाटप स्थिती कशी तपासावी?

Earkart Limited is a HealthTech platform specializing in hearing aids and related accessories, offering modern hearing devices including Receiver-In-Canal, Invisible, Behind-The-Ear, In-The-Ear, In-The-Canal, and Completely-In-Canal models, incorporated with operations through network of partners, clinics, and Shop in Shop model across 49 clinics in 22 cities spanning 6 states and 2 Union Territories, while also distributing adjustable foldable walkers and Multi-Sensory Integrated Educational Development materials for physically challenged individuals, operating manufacturing facility in Noida across 4,500 square feet and serving as trusted Government e-Market supplier of hearing aids to ALIMCO under Ministry of Social Justice and Empowerment.

The Earkart IPO came with a total issue size of ₹49.26 crore, comprising a fresh issue of 0.33 crore shares aggregating to ₹44.75 crore and offer for sale of 0.03 crore shares aggregating to ₹4.51 crore. The IPO opened on September 25, 2025, and closed on September 29, 2025. The allotment for the Earkart IPO is expected to be finalized on Tuesday, September 30, 2025. The Earkart IPO share price was fixed at ₹135 per share.

पुढील मोठा IPO चुकवू नका - केवळ काही क्लिकसह इन्व्हेस्ट करा!

आत्ताच अकाउंट उघडा

Steps to Check Earkart IPO Allotment Status on Registrar Site

• भेट द्या स्कायलाईन फायनान्शियल सर्व्हिसेस प्रा.लि. वेबसाईट
• Select "Earkart" from the dropdown menu on the allotment status page
• नियुक्त क्षेत्रात तुमचा PAN ID, डिमॅट अकाउंट नंबर किंवा ॲप्लिकेशन नंबर प्रविष्ट करा
• कॅप्चा पडताळणी प्रक्रिया पूर्ण करा आणि तुमची वाटप स्थिती पाहण्यासाठी "सबमिट करा" बटनावर क्लिक करा

Steps to Check Earkart IPO Allotment Status on BSE

• BSE SME IPO वाटप स्थिती पेज वर नेव्हिगेट करा
• समस्या प्रकार निवडा: इक्विटी/डेब्ट
• Choose "Earkart" from the list of active IPOs in the dropdown menu
• आवश्यक क्षेत्रांमध्ये तुमचा ॲप्लिकेशन नंबर आणि PAN ID प्रविष्ट करा
• कॅप्चा पडताळा आणि तुमची वाटप स्थिती तपासण्यासाठी "शोधा" वर क्लिक करा

इअरकार्ट Ipo सबस्क्रिप्शन स्थिती

Earkart IPO received weak investor interest, being subscribed 1.28 times overall. The subscription showed poor confidence with weak retail participation and moderate NII interest. सप्टेंबर 29, 2025 रोजी 5:05:35 PM पर्यंत सबस्क्रिप्शनचे कॅटेगरी-निहाय ब्रेकडाउन येथे दिले आहे:

• नॉन-इन्स्टिट्यूशनल इन्व्हेस्टर (एनआयआय): 1.63 वेळा.
• वैयक्तिक इन्व्हेस्टर: 0.35 वेळा.

Earkart IPO Share Price and Investment Details

The Earkart IPO stock price was fixed at ₹135 per share with a minimum lot size of 1,000 shares. 2 लॉट्स (2,000 शेअर्स) साठी रिटेल इन्व्हेस्टरसाठी आवश्यक किमान इन्व्हेस्टमेंट ₹2,70,000 होते. इश्यूमध्ये मार्केट मेकरला वाटप केलेले 1,85,000 शेअर्स ₹2.50 कोटी उभारण्याचा समावेश आहे. Given the weak subscription response of 1.28 times overall, with particularly poor retail participation at 0.35 times and moderate NII interest, the Earkart IPO share price is expected to list with flat to negative premium.

IPO उत्पन्नाचा वापर

IPO द्वारे उभारलेले फंड खालीलप्रमाणे वापरले जातील:

• वाढत्या खेळत्या भांडवलाची आवश्यकता: ₹ 21.10 कोटी.
• Capital expenditure for setting up Shop in Shop Business Model and Infrastructure: ₹17.33 crore.
• सामान्य कॉर्पोरेट उद्देश: ₹ 0.63 कोटी.

बिझनेस ओव्हरव्ह्यू

Earkart Limited operates with diversified product portfolio in growing HealthTech sector, multi-channel distribution network spanning online, offline, and B2G sales, expanding Shop in Shop franchise model presence, and government recognition as trusted GeM supplier while demonstrating strong financial performance with 35% revenue increase and 125% PAT rise between FY24-FY25, maintaining healthy financial metrics with 34.55% ROE and low debt-equity ratio of 0.26. The company enjoys niche positioning in hearing aids and assistive devices segment, positioned to benefit from India's aging population and healthcare accessibility trends, though the aggressive pricing reflected in high P/E ratio of 26.98 post-issue and extremely weak retail response with poor overall subscription suggest investors should carefully evaluate valuation versus growth prospects in the competitive HealthTech sector before considering investment.